Real-world evaluation of second line chemotherapy for patients with advanced non-small cell lung cancer harboring preexisting interstitial lung disease

JOURNAL ARTICLE published February 2022 in Investigational New Drugs

Authors: Satoshi Igawa | Masanori Yokoba | Akira Takakura | Shinji Hosotani | Yoshiro Nakahara | Takashi Sato | Hisashi Mitsufuji | Jiichiro Sasaki | Katsuhiko Naoki